Protective Effects of D-Trp6-LH-RH Microcapsules Against Ovarian Damage from Cyclophosphamide in Rats
Author Information
Author(s): L. Bokser, B. Szende, A.V. Schally
Primary Institution: Endocrine, Polypeptide and Cancer Institute, Veterans Administration Medical Center, New Orleans, LA
Hypothesis
Can D-Trp6-LH-RH microcapsules protect female rats from ovarian damage caused by cyclophosphamide?
Conclusion
D-Trp6-LH-RH microcapsules effectively prevent ovarian injury caused by cyclophosphamide in female rats.
Supporting Evidence
- D-Trp6-LH-RH microcapsules prevented the reduction in the number and diameter of ovarian follicles caused by cyclophosphamide.
- Control animals showed significant ovarian damage, while those treated with D-Trp6-LH-RH did not.
- Three months after treatment, rats receiving D-Trp6-LH-RH had higher body weights compared to those treated with cyclophosphamide alone.
Takeaway
This study shows that a special hormone treatment can help protect the ovaries of female rats from damage caused by a cancer drug.
Methodology
Female Sprague-Dawley rats were divided into four groups and treated with either saline, D-Trp6-LH-RH microcapsules, cyclophosphamide, or a combination of both, followed by evaluation of ovarian health.
Limitations
The study was conducted on rats, and results may not directly translate to humans.
Participant Demographics
Female Sprague-Dawley rats, weighing 200-250 g.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website